Our commitment

Mini-movie time - keeping it sustainable at Roche

Investing in a sustainable future

Only financially successful companies can be active in addressing environmental and social concerns. And at Roche we have long recognised that only environmentally and socially responsible companies can achieve sustainable financial success.

Following a simple formula

Since 1896 we have followed a simple formula: when we go about our business responsibly, we succeed. Our daily work is to discover and develop novel medicines and solutions that improve patient health and quality of life. As we see it, that is our most significant contribution to society.

Our products and services not only save lives and ease suffering, they also create economic value. The right medication, received in time and at the right dose, hastens recovery and alleviates the most serious – and costly – effects of a disease. This can shorten or even avoid hospital stays. Patients can return to work sooner and reduce earnings lost through illness.

We believe these overall social and economic benefits provide sustainable value beyond just our medicines or diagnostics themselves.

Integrating sustainability into our business

As we see it, our primary responsibility is to remain an active, forward-looking company developing differentiated solutions for the complex business of healthcare delivery. This will enable Roche to create superior value for employees, for patients and the medical profession and for investors and the communities where Roche does business.

For us, the business case for sustainability requires a long-term perspective, not only by Roche, but also by its shareholders and other stakeholders.

Perhaps it is inevitable that Roche views its responsibilities in this way. After all, our business – the discovery, development and production of innovative solutions to unmet medical needs – is inherently a long-term undertaking. It requires courage, determination and independent thinking to invest in new products which typically take up to 12 years to develop.  It also takes highly skilled, independent and highly motivated employees, on an open and arms-length interaction with the medical and scientific communities, and on transparent relationships with regulators, customers and suppliers.

The 2030 United Nations Sustainable Development Goals:

In September 2015, the United Nations General Assembly unanimously adopted 17 new “Sustainable Development Goals” (SDGs) to end poverty, protect the planet, and ensure prosperity for all as part of the 2030 Sustainable Development Agenda. This agreement marks an important milestone in the next phase of sustainable development with the engagement of a wide range of stake-holders.


Roche is committed to support the UN SDGs

Improving and saving lives is at the core of our Roche philosophy. We have been pursuing this commitment for almost 120 years and our mission today is still providing innovative healthcare solutions and making sure our medicines reach the patients who need them.

Roche contributes to a number of the 17 Sustainability Development Goals and its 169 specific targets within the sphere of our work. We are particularly pleased to see a dedicated goal on Health (SDG 3). This is important as health plays a crucial role in societal and economic development.

As a global healthcare company, our main contribution to sustainable business is researching and developing products to meet some of the most urgent medical needs. We are committed to achieving these goals together with governments, civil society and other stakeholders.

Quantifying sustainability performance

Sustainability can have a direct or indirect effect on value creation. For example, eco-efficiency initiatives that reduce costs have a visible financial impact. Attracting, developing and retaining the best people also have a direct impact on business value. On the other hand, the value created by transparent business practices and efforts to mitigate risk is less obvious, but equally important.

We have developed relevant and meaningful key performance indicators (KPIs) for measuring and monitoring progress in many areas of corporate responsibility. We also benchmark our achievements against the industry and best practices.

Today, Roche is viewed and rewarded as one of the most sustainable and responsible companies in the industry. In 2014, for the sixth consecutive year, Roche was recognised by the Dow Jones Sustainability Index (DJSI) as the Group Leader within the Pharmaceuticals, Biotechnology & Life Sciences Industry, based on an in-depth analysis of economic, social and environmental performance. Read more